Moreover, hijacking enhancers by forming ecDNA could modulate cell viability by regulating oncogene expression, as demonstrated in the case of EGFR in glioblastoma and MYCN in neuroblastoma (16, 43). The gene discussed is EGFR; the disease is glioblastoma.